Protective Effects of Selective Mineralocorticoid Receptor Antagonist in Alport Syndrome on Top of Renin-Angiotensin-System/ Sodium-Glucose Transporter 2 Blockade

Kidney Int Rep. 2023 Dec 23;9(3):730-731. doi: 10.1016/j.ekir.2023.12.014. eCollection 2024 Mar.

Zhuo-Ran Song^{1

2

3

4

5}, Yang Li^{1

2

3

4

5}, Hong Zhang^{1

2

3

4

5}, Xu-Jie Zhou^{1

2

3

4

5}

¹ Renal Division, Peking University First Hospital, Beijing, People's Republic of China.
² Kidney Genetics Center, Peking University Institute of Nephrology, Beijing, People's Republic of China.
³ Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, People's Republic of China.
⁴ Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, People's Republic of China.
⁵ State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, People's Republic of China.

No abstract available